Hoth Therapeutics to restructure as Rocket One, entering AI chip licensing deal with VCU

Hoth Therapeutics, Inc.

Exclusive licenses from VCU for nanomagnetic matrix multiplier (AI acceleration) and spintronic memory for defense/space.
Royalties: mid-single-digit % on net sales (patents), low-single-digit % for technical info, low-double-digit % on sublicensing.
Minimum annual payments low to mid five figures; one agreement had low-five-figure upfront fee.
Company intends to change name to Rocket One Inc.; restructuring approved by board to pursue AI semiconductor infrastructure.
Biotechnology assets will be placed in a separate wholly owned subsidiary to preserve value.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Hoth Therapeutics, Inc. entered into VCU License Agreements with Virginia Commonwealth University Intellectual Property Foundation (effective 2026-05-15).

Action: entry
Agreement: license
Counterparty: Virginia Commonwealth University Intellectual Property Foundation
Effective: 2026-05-15

Exact text from the filing

On May 15, 2026 (the "Effective Date"), Rocket One Inc. (“Rocket One”), a newly formed subsidiary of Hoth Therapeutics, Inc. (the “Company”), entered into two exclusive license agreements (collectively, the “VCU License Agreements”) with the Virginia Commonwealth University Intellectual Property Foundation (“VCU”) as further described below.

View on SEC.gov

38 material agreements filed in the last 30 days. Browse all material agreements →

Hoth Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-26-060075

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.